Editor's E-Note
A new study led by Rutgers University researchers and published in the journal Drug and Alcohol Dependence is shedding light on the link between cannabis use and cannabis use disorder among pregnant and postpartum women with specific mental health disorders, including bipolar disorder.
In addition to reading our e-newsletter, be sure to visit CRx’s website at www.CRxmag.com.
— Kate Jackson, editor |
|
|
|
|
Pregnant and Postpartum Women Self-Medicating
Pregnant and recently postpartum women who suffer from mental health disorders may be vulnerable to using cannabis to self-medicate, according to a Rutgers-led study.
In a nationally representative survey, Qiana L. Brown, PhD, MSW, MPH, an assistant professor at the Rutgers School of Social Work, examined the relationship between mental health disorders, cannabis use, and cannabis use disorder (CUD) among pregnant and postpartum women in the United States. The findings were published in the journal Drug and Alcohol Dependence.
“Before this study, we didn't know much about the associations between cannabis use, CUD, and specific mental health disorders, such as bipolar disorder or specific phobia, among pregnant and postpartum women in the US,” Brown says.
“Most prior research grouped mental health disorders into general classes, such as any mood disorder or any anxiety disorder, without examining the relationship between specific types of mood and anxiety disorders and cannabis use and CUD during and after pregnancy.”
Despite public health messaging encouraging women to abstain from using cannabis during pregnancy and while breast-feeding, the prevalence of cannabis use by women of reproductive age has been increasing.
|
The Role of Cannabis in Public Health
Salon Privé Magazine offers an overview of the place cannabis plays and the future it may have in public health, exploring the leading indications for its use.
Cannabis Improves Anxiety, Sleep Quality, and Quality of Life
A new British study published in Psychopharmacology has examined the effectiveness of cannabis-based medicinal products for individuals with generalized anxiety disorder. Hemp Gazette reports on the findings.
No Link Between Medical Cannabis Laws and Pain Treatment
According to a study of patients with chronic noncancer pain published in Annals of Internal Medicine, state medical cannabis laws have no bearing on the receipt of opioid or nonopioid pain treatment.
The LGBTQ+ Origins of Legal Cannabis
According to an article in CommonWealth Magazine, legalization of medical and adult use cannabis was made possible by members of the LGBTQ+ community who fought for access for AIDS/HIV+ patients in the early years of the AIDS crisis. |
Cannabis Crackers
Tempo has created low-dose THC crackers, each individually dosed. Three types of crackers are available: Awake, with 5 mg THC; Create, with 5 mg THC and 5 mg CBD; and Transcend, with 2 mg THC and 6 mg CBD. The crackers come in a variety of flavors, and unlike other edibles, they don’t melt. Learn more »
Delta 8 Gummies
Among a host of other products, 3Chi offers Delta 8 Gummies in several flavors, made from hemp grown in the United States. With 25 mg Delta 8 THC, they’re potent and long-lasting, as well as vegan and cruelty-free. Learn more »
Cannabis Science Conference
Get the latest expert-led science education at the Cannabis Science Conference, with keynotes, presentations, round table discussions, and exhibits. The conference takes place May 7 to 9, 2024, in Kansas City, Missouri. Learn more » |
| Advertising Opportunities |
| Have a product or service you want to market to professionals? Utilize the reach of CRx to accomplish your marketing goals. Email our experienced account executives today at sales@gvpub.com or call 800-278-4400 for more information. |
|
|
